When ebbu Founder and CEO Jon Cooper began to explore the possibilities of a launching a new cannabis business, the seasoned entrepreneur’s first thought on the plant’s chemistry was: “We’re dealing with lots of chaos here.”
The progress of cannabis research has been hampered in the U.S. by the federal status of marijuana. As we’ve learned at our ebbu laboratory headquartered in Colorado, having access to a variety of strains is crucial to conducting research.
Cannabis has long been used as medicine—going back at least 6,000 years around the world.
Researchers report that records of cannabis use date to 2,700 years ago in Ancient China, where it is believed to have been used as an anesthetic. It played a role in Ayurvedic medicine in India, and its use was also documented in Egyptian papyri.
This might just be the best job title ever: Cannabis product tester.
Even better, it’s a real opportunity from Colorado-based cannabis technology lab ebbu, which has spent the last two years conducting clinical research involving panels of adults trying out new products from the company’s high-science development laboratory.
Dr. Brian Reid, ebbu’s Chief Science Officer, is one of the leading minds in the cannabis industry. Dr. Reid oversees all of the research and development that takes place at ebbu, including chemistry, chromatography, cellular pharmacology, human pharmacology and genetics.